NOXXON to commence NOX-H94 Phase I trial in anemia of chronic disease

NOXXON Pharma today announced the initiation of a Phase I clinical trial for NOX-H94, the Company’s third compound to enter the clinic. NOX-H94 is a Spiegelmer designed to treat anemia of chronic disease by targeting the peptide hormone hepcidin, the key regulator of iron metabolism.

Docs Lobby UN to Take Action on Chronic Diseases

Dr. David Kerr reports on an international alliance of doctors who will press world leaders at an upcoming UN Summit to take 10 steps toward the global control of noncommunicable diseases. Medscape Hematology-Oncology

Modifying Risk Factors May Prevent Alzheimer’s Epidemic

A global model of Alzheimer’s risk suggests reducing chronic disease risk factors may prevent millions of cases and possibly prevent the projected epidemic threatening to overwhelm economic resources. Medscape Medical News

Study examines cost-effectiveness of MS drugs in the U.S.

A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms of MS and compared to treatments for other chronic diseases.

Tocotrienol could help reduce stroke damage

Preventive supplementation with a natural form of vitamin E called tocotrienol could help reduce brain damage caused by strokes, researchers reported today at the 2nd International Conference on Tocotrienols and Chronic Diseases.

Generics as a way to lower health care costs

As the nation seeks to expand health care coverage to more citizens without adding burdensome costs, researchers from Harvard University, Brigham and Women’s Hospital and CVS Caremark reported that preventative health care may be significantly less costly than previously thought, due to expanded use of cost-effective generic medications for the treatment and prevention of chronic [...]

Mother’s Body Size And Placental Size Predict Heart Disease In Men

Researchers investigating the foetal origins of chronic disease have discovered that combinations of a mother’s body size and the shape and size of her baby’s placenta can predict heart disease in men in later life. The research is published online today in the European Heart Journal[1]…

Musculoskeletal Comorbidities in Cardiovascular Disease, Diabetes and Respiratory Disease: The Impact on Activity Limitations; A Representative Population-based Study

Musculoskeletal conditions arise often in the presence of other chronic diseases. How can they be prevented? BMC Public Health

2011 BIO International Convention To Host New Forum On Diabetes

In an effort to raise awareness for one of the most costly chronic diseases facing adults and children, the Biotechnology Industry Organization (BIO), together with the Juvenile Diabetes Research Foundation (JDRF), will feature a two-day diabetes forum for the first time at its 2011 BIO International Convention. The Convention will take place June 27-30, [...]

Estrogen-Only HRT Less Risky For Younger Women, More Risky For Older Ones

A woman in her 50s who has had a hysterectomy has much lower health risks when receiving estrogen-only replacement hormone therapy, compared to a woman in her 70s, whose has a higher risk of developing chronic disease, colorectal cancer, and even dying…